SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Continente #
NA - Nord America 4.416
EU - Europa 2.026
AS - Asia 970
SA - Sud America 17
OC - Oceania 10
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.452
Nazione #
US - Stati Uniti d'America 4.375
DE - Germania 450
SG - Singapore 366
IE - Irlanda 323
IT - Italia 323
CN - Cina 301
RU - Federazione Russa 285
SE - Svezia 278
HK - Hong Kong 150
AT - Austria 94
GB - Regno Unito 82
UA - Ucraina 63
VN - Vietnam 51
CA - Canada 36
FI - Finlandia 30
ID - Indonesia 30
IN - India 29
DK - Danimarca 28
FR - Francia 21
BE - Belgio 14
BR - Brasile 13
NL - Olanda 13
TR - Turchia 12
JP - Giappone 9
AU - Australia 7
PH - Filippine 6
MK - Macedonia 5
EU - Europa 4
IR - Iran 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
KR - Corea 3
MX - Messico 3
NZ - Nuova Zelanda 3
PL - Polonia 3
TH - Thailandia 3
BJ - Benin 2
CL - Cile 2
ES - Italia 2
MU - Mauritius 2
NG - Nigeria 2
PE - Perù 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CH - Svizzera 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
TW - Taiwan 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 7.452
Città #
Ann Arbor 877
Fairfield 495
Frankfurt am Main 381
Chandler 316
Dublin 312
Singapore 293
Wilmington 251
Ashburn 235
Woodbridge 221
Houston 207
Seattle 204
New York 153
Hong Kong 150
Dearborn 139
Princeton 130
Cambridge 124
Milan 104
Vienna 92
Santa Clara 90
Jacksonville 72
Altamura 58
Lawrence 56
Nanjing 49
Shanghai 41
Beijing 37
Dong Ket 33
San Diego 33
Jakarta 29
Lissone 23
Andover 19
Boardman 19
Helsinki 18
Nanchang 17
Toronto 16
Kunming 15
Guangzhou 14
London 13
Brussels 12
Jiaxing 12
Shenyang 12
Tianjin 11
Los Angeles 10
Hebei 9
Jinan 9
Moscow 9
Atlanta 8
Falls Church 8
Changsha 7
Edmonton 7
Lachine 7
Monza 7
Sacramento 7
Bonndorf 6
Concorezzo 6
Esslingen am Neckar 6
Norwalk 6
Pune 6
São Paulo 6
Akatsuka-shinmachi 5
Copenhagen 5
Fremont 5
Fuzhou 5
Kiev 5
Mountain View 5
Phoenix 5
Bologna 4
Chicago 4
Groningen 4
Hangzhou 4
Hounslow 4
Lakeville 4
Lappeenranta 4
Munich 4
Ningbo 4
Ottawa 4
Redmond 4
San Mateo 4
Skopje 4
Brasília 3
Brno 3
Changchun 3
Chelyabinsk 3
Gliwice 3
Hefei 3
Middle River 3
New Bedfont 3
Owasso 3
Pioltello 3
Taizhou 3
Zhengzhou 3
Ardea 2
Assago 2
Avellino 2
Bergamo 2
Carate Brianza 2
Chengdu 2
Chiang Rai 2
Chiswick 2
Cinisello Balsamo 2
Ciudad Valles 2
Totale 5.650
Nome #
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 246
Heart rate as cardiovascular risk factor 235
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 231
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 188
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 188
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 185
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 184
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 178
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 169
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 166
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 163
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 161
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 156
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 155
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 153
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 153
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 151
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 151
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 147
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 138
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 132
The role of carotid baroreceptor stimulation 130
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 130
Baroreflex activation therapy systems: current status and future prospects 129
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 125
Sympatho-Vagal Imbalance in Hypertension 121
The role of brain in neurogenic prehypertension 120
Effects of Renal Denervation on Sympathetic Nervous System Activity 117
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 112
Blood pressure measurement, white-coat and masked hypertension 110
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 109
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 108
Sympathetic Nervous System, Sleep, and Hypertension 107
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 103
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 102
Heart rate as a predictor of cardiovascular risk 97
Treatment of resistant hypertension 90
Obesity and hypertension 90
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 89
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 88
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 87
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 85
Cigarette smoking and the adrenergic nervous system 84
Lercanidipine in the management of hypertension: An update 83
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 82
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 77
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 75
Neurohormonal interactions 72
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 72
Arterial alterations in hypertension 70
Neural Mechanisms 69
Cardiovascular physiology: regulation of blood pressure 65
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 64
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 63
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 60
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 59
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 59
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 57
Trained Athletes 56
Clinical relevance of the sympathetic–vascular interactions in health and disease 56
Elevated heart rate as sympathetic biomarker in human obesity 54
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 54
Sleep Apnea and Hypertension 53
Sympathomodulation in congestive heart failure: From drugs to devices 52
Baroreceptor Stimulation 52
Microvascular Alterations in Obesity 50
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 50
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 48
The sympathetic nervous system in hypertension 46
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 46
New-onset aortic dilatation in the population: a quarter-century follow-up 41
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 35
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 34
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 30
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 22
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 18
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 16
Totale 7.803
Categoria #
all - tutte 32.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020563 0 0 0 0 0 135 126 76 73 80 51 22
2020/20211.490 106 198 122 113 81 108 160 158 116 115 87 126
2021/2022970 81 87 106 57 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/2025931 150 318 112 92 196 63 0 0 0 0 0 0
Totale 7.803